CVS Health Co. (NYSE:CVS) Position Boosted by Navalign LLC

Navalign LLC increased its holdings in CVS Health Co. (NYSE:CVS) by 2.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 11,353 shares of the pharmacy operator’s stock after buying an additional 232 shares during the period. Navalign LLC’s holdings in CVS Health were worth $896,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Live Oak Investment Partners bought a new stake in shares of CVS Health in the 4th quarter valued at approximately $25,000. Atticus Wealth Management LLC boosted its holdings in CVS Health by 149.0% in the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares during the last quarter. Cornerstone Planning Group LLC lifted its position in CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 243 shares during the period. ZRC Wealth Management LLC grew its holdings in CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after acquiring an additional 400 shares during the period. Finally, True Wealth Design LLC bought a new position in shares of CVS Health in the 4th quarter worth $48,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Piper Sandler boosted their target price on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, March 15th. Royal Bank of Canada reduced their target price on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. StockNews.com downgraded CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. SVB Leerink initiated coverage on shares of CVS Health in a report on Monday, February 26th. They set an “outperform” rating and a $88.00 target price on the stock. Finally, HSBC assumed coverage on shares of CVS Health in a research report on Friday, December 22nd. They issued a “buy” rating and a $94.00 price objective for the company. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $90.21.

CVS Health Price Performance

NYSE:CVS traded up $0.33 during trading hours on Thursday, hitting $79.76. The company’s stock had a trading volume of 8,872,358 shares, compared to its average volume of 11,297,311. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The company has a market capitalization of $100.37 billion, a P/E ratio of 12.37, a PEG ratio of 1.05 and a beta of 0.51. CVS Health Co. has a twelve month low of $64.41 and a twelve month high of $83.25. The stock has a fifty day simple moving average of $75.66 and a 200-day simple moving average of $73.46.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. The firm had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the business posted $1.99 earnings per share. On average, analysts anticipate that CVS Health Co. will post 8.33 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.34%. CVS Health’s payout ratio is currently 41.18%.

Insider Transactions at CVS Health

In related news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.25% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.